Table 1.
Population characteristics (845 subjects) | |
---|---|
Anthropometric and preoperative parameters | |
| |
Gender (f/m, %) | 34.4/65.6 |
Age (years) | 62.40 ± 13.14 |
BMI (kg/m2) | 25.28 ± 4.11 |
Plasma creatinine (mg/dL) | 0.90 ± 0.23 |
eGFR (mL/m 1.73 m2) | 80.25 ± 20.47 |
Hypertension (%) | 55.4 |
Diabetes (%) | 14.5 |
Peripheral vascular disease (%) | 17.7 |
Chronic obstructive pulmonary disease (%) | 11.5 |
EuroSCORE | 4.03 ± 4.54 |
CLIN-RISK# | 9.38 ± 4.08 |
Plasma EO (pmol/L)∗ | 174 [118–241] |
204.62 ± 145.96 | |
NT-ProBNP (pg/mL) | 680.72 ± 910.53 |
| |
Cardiological characteristics | |
| |
Left ventricular ejection fraction (%) | 56.98 ± 10.27 |
Class LVEF (%) | |
<30% | 3.3 |
30–50% | 19.9 |
>50% | 76.8 |
Interventricular septum (mm) | 11.31 ± 2.12 |
Cardiac End-Diastolic Diameter (mm) | 53.86 ± 7.95 |
NYHA classification (%) | |
I | 22.1 |
II | 55.9 |
III | 21.0 |
IV | 1.1 |
| |
Surgical characteristics | |
| |
Surgery type (%) | |
Valve repair (VR) | 49.5 |
Isolated coronary bypass (CABG) | 16.3 |
CABG + VR | 18.5 |
Aortic Arch surgery | 13.3 |
Other | 2.2 |
Reoperation cardiac surgery (%) | 10.7 |
Combined surgery (%) | 18.6 |
Cardiopulmonary bypass used (%) | 88.9 |
Cardiopulmonary bypass duration (min) | 68.85 ± 30.04 |
| |
Postoperative time | |
| |
Plasma creatinine (mg/dL) | 1.20 ± 0.63 |
Plasma EO (pmol/L)∗ | 267 [200–357] |
311.55 ± 200.70 | |
ΔPlasma EO (pmol/L) | 91.51 ± 195.52 |
| |
Outcomes | |
| |
AKI (%) | |
AKIN Stage I | 23.3 |
AKIN Stage II | 9.3 |
AKIN Stage II | 2.3 |
In-hospital mortality (n, %) | 14 (1.7%) |
Dichotomy variables: expressed as % (positive).
Parametric variables: expressed as mean ± s.d.
Nonparametric variables (∗): expressed as median (25–75 percentile) and mean ± s.d.